Parkinson’s disease (PD) is an age-related neurodegenerative disorder. The degeneration of the neurons of the substantia nigra in the midbrain leads to the loss of dopamine from the striatum, which is responsible for the motor symptoms of PD. In the brain, the enzyme, monoamine oxidase B (MAOB), An analysis of the Lineweaver-Burk plots indicated that 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)- quinolinone inhibits MAO-B with a Ki value of 2.7 nM. An analysis of the structure-activity relationships for MAO-B inhibition shows that substitution on the C7 position of the 3,4-dihydro- 2(1H)-quinolinone moiety leads to significantly more potent inhibition compared to substitution on C6. In this regard, a benzyloxy substituent on C7 is more favourable than phenylethoxy and phenylpropoxy substitution on this position. In spite of this, C6-substituted 3,4-dihydro-2(1H)-quinolinone with potent MAO-B inhibitory activities were also identified. An analyses of selected properties of the 3,4-dihydro-2(1H)- quinolinones showed that the compounds are highly lipophilic with logP values in the range of 3.03- 4.55. LogP values between 1 and 3 are, however, in the ideal range for bioavailability. The compounds synthesised have logP values higher than 3, which may lead to lower bioavailability. Laboratory data further showed that none of the 3,4-dihydro-2(1H)-quinolinones are highly toxic to cultured cells at the concentrations, 1 μM and 10 μM, tested. For example, the most potent MAO-B inhibitor, 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)-quinolinone, reduced cell viability to 88.11% and 86.10% at concentrations of 1 μM and 10 μM, respectively. These concentrations are well above its IC50 value for the inhibition of MAO-B. At concentrations required for MAO-B inhibition, the more potent 3,4-dihydro-2(1H)-quinolinones are thus unlikely to be cytotoxic. It may thus be concluded that C7-substituted 3,4-dihydro-2(1H)-quinolinones are promising highly potent and selective MAO-B inhibitors, and thus leads for the therapy of Parkinson’s disease. represents a major catabolic pathway of dopamine. Inhibitors of MAO-B conserve the depleted supply of dopamine and are thus used in the therapy of PD. In the present study, a series of 3,4- dihydro-2(1H)-quinolinone derivatives were synthesized and evaluated as inhibitors of recombinant human MAO-A and MAO-B. These quinolinone derivatives are structurally related to a series of coumarin (1-benzopyran-2-one) derivatives, which has been reported to act as MAO-B inhibitors. C6- and C7-substituted 3,4-dihydro-2(1H)-quinolinone derivatives were synthesized by reacting 6- or 7- hydroxy-3,4-dihydro-2(1H)-quinolinone with an appropriately substituted alkyl bromide in the presence of base. To evaluate the MAO inhibitory properties (IC50 values) of the quinolinone derivatives the recombinant human MAO-A and MAO-B enzymes were used. The reversibility of inhibition of a representative 3,4-dihydro-2(1H)-quinolinone derivative was examined by measuring the recovery of enzyme activity after the dilution of the enzyme-inhibitor complexes, while the mode of MAO inhibition was determined by constructing Lineweaver-Burk plots. To determine the lipophilicity of the 3,4-dihydro-2(1H)-quinolinone derivatives, the logP values were measured. The toxicity of the 3,4-dihydro-2(1H)-quinolinone derivatives towards cultured cells (cytotoxicity) was also measured. The results document that the 3,4-dihydro-2(1H)-quinolinone derivatives are highly potent and selective MAO-B inhibitors with most homologues exhibiting IC50 values in the nanomolar range. The most potent MAO-B inhibitor, 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)-quinolinone, exhibits an IC50 value of 2.9 nM with a 2750-fold selectivity for MAO-B over the MAO-A isoform. As a MAO-B inhibitor, this compound is approximately equipotent to the most potent coumarin derivative (IC50 = 1.14 nM) reported in literature. Since MAO-B activity could be recovered after dilution of enzyme-inhibitor mixtures, it may be concluded that 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)- quinolinone is a reversible MAO-B inhibitor. The Lineweaver-Burk plots constructed for the inhibition of MAO-B by 7-(3-bromobenzyloxy)-3,4-dihydro-2(1H)-quinolinone were linear and intersected on the y-axis. These data indicated that this compound also is a competitive MAO-B inhibitor. / MSc (Pharmaceutical Chemistry), North-West University, Potchefstroom Campus, 2014

Very little is known about why and how the Parkinson's disease (PD) neurodegenerative process begins and progresses. In the course of developments for treatment of PD, the discovery of the inhibition of monoamine oxidase (MAO B) was a conceptual breakthrough, and has now been firmly established. MAO B has also been implicated in the neurodegenerative processes resulting from exposure to xenobiotic amines. For example, MAO B catalyzes the first step of the bioactivation of the parkinsonian inducing pro-neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Additional insight into the mechanism of catalysis of MAO B and the mechanism of neurotoxicity by MPTP is therefore very valuable in the pursuit of the treatment of PD. / Thesis (Ph.D. (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2008.

Very little is known about why and how the Parkinson's disease (PD) neurodegenerative process begins and progresses. In the course of developments for treatment of PD, the discovery of the inhibition of monoamine oxidase (MAO B) was a conceptual breakthrough, and has now been firmly established. MAO B has also been implicated in the neurodegenerative processes resulting from exposure to xenobiotic amines. For example, MAO B catalyzes the first step of the bioactivation of the parkinsonian inducing pro-neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Additional insight into the mechanism of catalysis of MAO B and the mechanism of neurotoxicity by MPTP is therefore very valuable in the pursuit of the treatment of PD. / Thesis (Ph.D. (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2008.

Biologically active peptides are important for many physiological functions in the human body and therefore serve as interesting starting points in drug discovery processes. In this work the neuropeptide substance P 1–7 (SP1–7, H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-OH), which has been demonstrated to reduce neuropathic pain and attenuate opioid withdrawal symptoms in animal models, has been addressed in a medicinal chemistry program with the overall aim of transforming this bioactive peptide into more drug-like compounds. Specific binding sites for this neuropeptide have been detected in the brain and the spinal cord. Interestingly, the smaller neuropeptide endomorphin-2 (EM-2, H-Tyr-Pro-Phe-Phe-NH2) also interacts with these binding sites, although 10-fold less efficient. In this work the structure–activity relationship of SP1–7 and EM-2, regarding their affinity to the SP1–7 binding site was elucidated using alanine scans, truncation, and terminal modifications. The C-terminal part of both peptides, and especially the C-terminal phenylalanine, was crucial for binding affinity. Moreover, the C-terminal functional group should preferably be a primary amide. The truncation studies finally resulted in the remarkable discovery of H-Phe-Phe-NH2 as an equally good binder as the heptapeptide SP1–7. This dipeptide amide served as a lead compound for further studies. In order to improve the drug-like properties and to find a plausible bioactive conformation, a set of rigidified and methylated dipeptides of different stereochemistry, and analogs with reduced peptide character, were synthesized and evaluated regarding binding, metabolic stability and absorption. Small SP1–7 analogs with retained affinity and substantially improved permeability and metabolic stability were identified. Beside peptide chemistry the synthetic work included the development of a fast and convenient microwave-assisted protocol for direct arylation of imidazoles. Furthermore, microwave-assisted aminocarbonylation using Mo(CO)6 as a solid carbon monoxide source was investigated in the synthesis of MAP amides and for coupling of imidazoles with amino acids. In a future perspective the present findings, together with the fact that some of the SP1–7 analogs discovered herein have been shown to reproduce the biological effects of SP1-7 in animal studies related to neuropathic pain and opioid dependence, can ultimately have an impact on drug discovery in these two areas.

Submitted by Maike Costa (maiksebas@gmail.com) on 2017-09-13T12:15:49Z No. of bitstreams: 1 arquuivototal.pdf: 3577415 bytes, checksum: 0e9d2a60e77718e50720d15b7cad6fb1 (MD5) / Made available in DSpace on 2017-09-13T12:15:49Z (GMT). No. of bitstreams: 1 arquuivototal.pdf: 3577415 bytes, checksum: 0e9d2a60e77718e50720d15b7cad6fb1 (MD5) Previous issue date: 2016-02-18 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / In recent decades fungal infections have increased, and their high rates of morbidity and mortality have brought them much attention. Immunocompromised patients are more susceptible to microorganism infections; in particular, fungal species of the genus Aspergillus spp. Among the current infectious filamentous fungi they have a rather high incidence. Antifungal treatments have been subjected to numerous studies, and the increasing number of resistant fungal species has been highlighted. Thus, we see the importance of seeking new, more effective, and less toxic therapeutic sources. The aim of this study was to evaluate the in vitro antifungal activity and structure activity relationships of coumarin compounds against Aspergillus species. For this the MIC of 24 coumarin compounds was determined and subsequent SAR studies were performed with computer software. 12 of the 24 tested coumarin derivatives have antifungal activity, with 5 has shown excelent activity. Thus two derivatives, 7-hydroxy-6-nitrocoumarin (Cou-UNO2), and 4-acetoxycoumarin (Cou-UMB16), with better MIC values were evaluated via inhibition of mycelial growth and conidial germination, and by mechanism of action testing. The products were evaluated in combination with antifungals standards. The results showed that 12 of the 24 tested coumarin derivatives have antifungal activity, with MIC values ranging from 1024-16μg/ml. SAR studies have showed that the presence of a short aliphatic chain, and/or electronegative groups like ring substituents are favorable for antifungal activity. The coumarin derivatives with better MIC values (16μg/ml); Cou-UNO2 and Cou-UMB16 were capable of inhibiting both the mycelial growth and conidial germination of Aspergillus spp. Their activity is on the structure of the fungal cell wall. Cou-NO2, in a sub-inhibitory concentration, enhanced the in vitro effects of azoles, and in combination with azoles (voriconazole and itraconazole) there was an additive effect. Cou-UMB16 in combination with azoles (voriconazole and itraconazole) had synergistic or additive effects depending on the strain used. Thus this study concludes that coumarin derivatives have antifungal activity against the species A. flavus and A. fumigatus. The coumarin Cou-UMB16 and Cou-UNO2 have able to inhibit the mycelial growth and conidio germination and that this activity is due to its action on the fungal cell wall and the presence of electronegative groups as substituents of the benzopyrone ring favors this activity. / As infecções fúngicas, nas últimas décadas, têm se destacado devido ao seu crescente aumento e suas elevadas taxas de morbidade e mortalidade. Pacientes imunocomprometidos são os que possuem maior susceptibilidade a estes micro-organismos. Dentre estas infecções fúngicas, as espécies pertencentes ao gênero Aspergillus spp. possuem alta incidência entre os fungos filamentosos. A terapêutica antifúngica tem sido alvo de numerosos estudos e nestes tem sido destacado o crescente aumento de espécies fúngicas resistentes. Dessa forma, destaca-se a importância da busca de novas fontes terapêuticas que se apresentem mais eficazes e com menos tóxicas ao hospedeiro. Assim o objetivo deste estudo foi avaliar a atividade antifúngica in vitro e relação estrutura atividade (SAR) dos compostos cumarínicos frente às espécies do gênero Aspergillus. Para tal foi determinada a CIM de 24 compostos cumarínicos e posteriormente realizado estudos SAR com softwares computacionais. Dos 24 compostos ensaiados, 12 demonstraram possuir atividade antifúngica e 5 obtiveram forte atividade antifúngica. Destes derivados cumarínicos com forte atividade antifúngica, dois merecem destaque, 7-hidroxi-6-nitrocumarina (Cou-UNO2) e 4-acetóxicumarina (Cou-UMB16), com melhores valores de CIM, foram avaliados via testes de inibição do crescimento micelial, germinação dos conídios e testes de determinação do mecanismo de ação. Por fim os produtos foram avaliados em combinação com antifúngicos padrões. Os resultados demonstraram que 12 derivados cumarínicos dos 24 ensaiados possuem atividade antifúngica, com valores de CIMs variando entre 1024-16μg/mL. A SAR demonstra que a adição de grupos eletronegativos, como substituintes do anel benzopirona, favorece a atividade antifúngica destes compostos. Os derivados cumarínicos com melhores CIM (16μg/mL), 7-hidroxi-6-nitrocumarina (Cou-UNO2) e 4-acetóxicumarina (Cou-UMB16) foram capazes de inibir o crescimento micelial e a germinação dos conídios de Aspergillus spp. E estes possuem ação sobre a estrutura da parede celular fúngica. Em uma concentração subinibitória, Cou-UNO2 potencializou a ação in vitro dos derivados azólicos e em combinação com os derivados azólicos (voriconazol e itraconazol) observou-se um efeito aditivo. Já Cou-UMB16 em combinação com os derivados azólicos (voriconazol e itraconazol) obteve um efeito sinérgico a aditivo, dependendo da linhagem utilizada. Logo este estudo conclui que os derivados cumarínicos possuem atividade antifúngica contra as espécies de A. flavus e A. fumigatus. As cumarinas Cou-UNO2 e Cou-UMB16 foram capazes de inibir o crescimento micelial e a germinação dos conídios e que esta atividade seja devido a sua ação sobre a parede celular fúngica. E que esta atividade é favorecida pela presença de moléculas eletronegativas no anel básico da cumarina (1,2-benzopirona).

Made available in DSpace on 2015-05-14T13:21:44Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 4637140 bytes, checksum: f9c50e9a2115f5a805442d163ed54f1e (MD5) Previous issue date: 2012-12-14 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / The Morita-Baylis-Hillman Adducts (MBHA) is a class of molecules studied by our research group on synthetic, theoretical and bioactivity aspects. In this work, we present Quantitative Structure-Activity Relationship (QSAR) models involving 32 aromatic MBHA. Initially, the most stable conformations of thirty-two MBHA were investigated by theoretical methods, which were used to construct models. For this study, were obtained potential energy curves using AM1 semi-empirical method, considering rotational degrees of freedom (sigma bonds). From these curves, the less energy conformation to each molecule was selected and optimized at B3LYP/6- 31+G(d) level, considering solvent effects through Polarizable Continuum Model (PCM). Proton Nuclear Magnetic Ressonance data are in agreement with the conformational study. Intramolecular Hydrogen Bonds (IHB) are presents in the most of the studied compounds, according to structural characterization and QTAIM calculations. Curiously, compounds that showed hydrogen bonds involving the nitro and hydroxyl groups have the best values of biological activity (IC50). An explanation is based on redox mechanism of action of nitrocompounds. NBO (Natural Bond Orbital) charges and LUKO (Lowest Unoccupied Kohn-Sham Orbitals) analysis at the ortho-nitro group are in agreement with these analyses. Considering quantum calculations and structural observations, four descriptors were selected a priori and submitted to a QSAR study using PLS (Partial Least Squares) and MLR (Multiple Linear Regression) modeling. A second QSAR approach was made from the another set of descriptors obtained through the online platform E-DRAGON, which were submitted to a variable selection method. The quality parameters obtained for models indicate that both are robust and predictive. / Os Adutos de Morita-Baylis-Hillman (AMBH) compreendem uma classe de moléculas investigadas por nosso grupo de pesquisas nos aspectos sintéticos, teóricos e de bioatividade. Neste trabalho, apresentamos modelos de Relação Quantitativa entre a Estrutura Química e a Atividade Leishmanicida (QSAR) envolvendo 32 AMBH aromáticos. Deste modo, inicialmente foram investigadas as conformações mais estáveis de cada composto através de métodos teóricos, as quais foram utilizadas na construção dos modelos. Foram obtidas curvas de energia potencial utilizando o método semi-empírico AM1, considerando graus de liberdade rotacionais (ligações sigma). A partir destas curvas, a conformação de menor energia para cada molécula foi selecionada e otimizada ao nível B3LYP/6-31+G(d), considerando os efeitos do solvente aquoso usando PCM ( Polarizable Continuum Model ). Dados espectroscópicos de Ressonância Magnética Nuclear de prótons corroboraram o estudo conformacional. Ligações de Hidrogênio Intramoleculares (LHI) se mostraram presentes na maioria das moléculas estudadas, conforme caracterização estrutural e cálculos QTAIM ( Quantum Theory Atoms in Molecules ). Curiosamente, os compostos que apresentaram Ligações de Hidrogênio envolvendo o grupo nitro (NO2) e a hidroxila (OH) possuem melhores valores de atividade biológica (menor IC50). Uma explicação está baseada no mecanismo de ação redox de nitrocompostos. Observação das cargas NBO ( Natural Bond Orbitals ) e análise dos orbitais de fronteira LUKO ( Lowest Unoccupied Kohn-Sham Orbitals ) ao nível do grupo orto-nitro estão de acordo com estas análises. Considerando os cálculos quânticos, bem como observações estruturais, quatro descritores foram selecionados a priori e submetidos a um estudo QSAR ( Quantitative Structure- Activity Relationships ) utilizando modelagem PLS ( Partial Least Squares ) e MLR ( Multiple Linear Regression ). Uma segunda abordagem QSAR foi realizada a partir de outro conjunto de descritores obtidos através da plataforma online E-DRAGON, os quais foram submetidos ao método de seleção de variáveis OPS ( Ordered Predictor Selection ). Os parâmetros de qualidade obtidos para os modelos indicam que ambos são robustos e preditivos.

Os neutrófilos desempenham um papel fundamental na defesa do organismo contra microrganismos invasores, através da fagocitose, da degranulação e da produção de espécies reativas de oxigênio (EROs), sendo que esta última é decorrente da ativação do metabolismo oxidativo dos neutrófilos. As EROs produzidas, tais como O2∙-, H2O2, HO∙, HOCl, 1O2 e NO, que são essenciais para matar os microrganismos fagocitados, podem também ser liberadas para o meio extracelular e causar lesões oxidativas aos tecidos do hospedeiro. Essas lesões têm sido implicadas na patogênese de doenças como aterosclerose, câncer, artrite reumatóide, pneumonia e enfisema pulmonar. Com o intuito de prevenir essas lesões oxidativas, tem-se investigado a atividade antioxidante de diversos compostos, especialmente os derivados de plantas. Neste trabalho foram avaliadas as atividades de oito cumarinas simples (compostos 1 a 8) sobre o metabolismo oxidativo de neutrófilos de coelho estimulados com Zimosan opsonizado, empregando-se os ensaios de quimioluminescência (QL) dependente de lucigenina (QLluc) e de QL dependente de luminol (QLlum). A QLluc reflete a produção apenas de O2∙- , enquanto que a QLlum é resultante da oxidação do luminol pelas diversas EROs produzidas pelos neutrófilos estimulados. Assim, a inibição da QLluc e da QLlum será decorrente da redução da concentração das EROs responsáveis pela oxidação da lucigenina e do luminol no meio de reação, respectivamente. Foram avaliadas também a atividade dos antioxidantes a-tocoferol, butil-hidroxitolueno (BHT) e quercetina sobre a QLlum e a QLluc, e a toxicidade das cumarinas 1 a 8 e dos três antioxidantes citados sobre os neutrófilos de coelho. Determinou-se o coeficiente de partição e o volume molecular das cumarinas 1 a 8. Dentre os três antioxidantes, observou-se que a quercetina inibiu tanto a QLlum quanto a QLluc, e não foi tóxica para os neutrófilos, na concentração de 50 mmol/L. O a-tocoferol não inibiu a QLlum nem a QLluc, enquanto o BHT foi tóxico para os neutrófilos de coelho. Para as cumarinas simples, observou-se que: (1) a cumarina 1 não apresentou atividade inibitória sobre a QLluc e sobre a QLlum; (2) as cumarinas 3, 4, 5 e 6 tiveram atividades inibitórias sobre a QLluc semelhantes à da quecetina, que foram maiores que as das cumarinas 2, 7 e 8; (3) as atividades inibitórias das cumarinas 2 a 8 sobre a QLluc não estão relacionadas à lipofilicidade e ao volume molecular desses compostos, nem à toxicidade dos mesmos sobre os neutrófilos de coelho; (4) as cumarinas 3 e 4 provocaram aumento da QLlum medida, enquanto as demais não tiveram atividade neste sistema. / Neutrophils play a crucial role in the defense of the organism against invading microorganisms, thorough phagocytosis, degranulation and generation of reactive oxygen species (EROS). The last one is a consequence of activation of neutrophils\' oxidative metabolism. The produced EROs, such as O2∙-, H2O2, HOCl, HO∙, 1O2 and NO, which are essential for killing phagocyted microorganisms, may also be released to the extracellular milieu and inflict oxidative damage to host tissues. This damage has been implicated in the pathogenesis of diseases, such as arteriosclerosis, cancer, rheumatoid arthritis, pneumonia and lung emphysema. The antioxidant activity of many compounds, especially those obtained from plants, has been investigated with the aim of avoid such oxidative damage. In this work, we studied the activity of eight simple coumarins (compounds 1 to 8) on the oxidative metabolism of rabbit neutrophils upon stimulation by opsonized zymosan, using luminol- (QLlum) and lucigenin (QLluc)-enhanced chemiluminescence (QL) assays. QLluc reflects generation of O2∙- only, whereas QLlum is a result of luminol oxidation by the various EROs produced by the stimulated neutrophils. Inhibition of QLluc and of QLlum will be a consequence of the decrease of the concentration of that EROs which are involved in the oxidation of lucigenin and luminol, respectively, in the reaction medium. We also evaluated the activity of the antioxidants a-tocopherol, butyl-hydroxytoluene (BHT) and quercetin on QLlum and QLluc, and the toxicity of coumarins 1 to 8 and the three antioxidants on rabbit neutrophils. Partition coefficient and molecular volume values of coumarins 1 to 8 were determined. We observed that, among the three antioxidants, quercetin inhibited QLlum and QLluc, and was not toxic to the neutrophils at concentration of 50 mmol/L. BHT was toxic to the rabbit neutrophils whereas a-tocopherol did not inhibit QLlum nor QLluc. For the simple coumarins we observed that: (1) coumarin 1 did not inhibit QLlum nor QLluc; (2) coumarins 3, 4, 5 and 6 had inhibitory effects, which were similar to the quercetin and higher than coumarins 2, 7 and 8; (3) the inhibitory activities of coumarins 2 to 8 on QLluc were not related to the lipophilicity and to the molecular volume of these compounds, nor to their toxicity upon the rabbit neutrophils; (4) coumarins 3 and 4 increased the QLlum, whereas the others had no effect on this system.

As estruturas e propriedades biológicas das amidas piplartina e a piperina, isoladas respectivamente de Piper tuberculatum e P. nigrum, inspiraram a síntese de 89 derivados e 7 esters estruturalmente relacionadas. As preparações envolveram metodologias tradicionais e os compostos purificados tiveram suas estruturas caracterizadas por análises espectroscópicas e espectrométricas. Os estudos de fragmentação por IE e IES indicaram a clivagem preferencial da ligação N-CO no caso das cinamamidas, dienamidas e cinamimidas. Estudos computacionais envolvendo afinidade protônica e energias de ligação confirmaram a fragmentação preferencial da ligação amídica para as amidas. A citotoxicidade de 89 substâncias foi avaliada contra três células leucêmicas (K562, Nalm6 e Raji) e a partir dos valores de IC50 foram realizados estudos de relação estrutura-atividade (SAR). As linhagens K562 e a Nalm6 foram a mais resistente e vulnerável, respectivamente, e as amidas piplartina (1a), N-Ciclohexil-N-(ciclohexilcarbamoil)-3-(3,4,5-trimetoxifenil)propanamida (1n), e (E)-N,N-dibutil-3-(3,4-dimetoxifenil)acrilamida (13h) foram as mais ativas com IC50 de 0,34 µM; 0,84 µM e 1,88 µM contra K562 e (E)-N-ciclohexil-N-(ciclohexilcarbamoil)-3-(3,4-dimetoxifenil)acrylamida (13i) com IC50 de 0,98 µM contra Nalm6. A avaliação de atividade leishmanicida de 18 substâncias não se mostrou promissora. As abordagens qualitativas e quantitativas foram feitas baseadas nos descritores moleculares gerados pelo programa VolSurf+. A partir de métodos quimiométricos tais com PLS, algoritmo genético, árvores de decisão foi possível gerar modelos para correlacionar às propriedades moleculares com a atividade biológica. As propriedades de absorção, distribuição, metabolismo e excreção e os equilíbrios entres as regiões hidrofílicas e hidrofóbicas foram importantes para atividade citotóxica. O estudo de ancoragem molecular mostrou que as amidas (E)-N,N-dibutil-3-(3,4,5-trimetoxifenil)acrilamida (1l), 1n, (E)-3-(4-clorofenil)-N-ciclohexil-N-(ciclohexilcarbamoil)acrilamida (5a), 13h e 13i podem atuar como inibidores das histonas desacetilases particularmente HDAC4 e HDAC8. / The structures and biological properties of the amides piplartine and piperine isolated from Piper tuberculatum and P. nigrum respectively, inspired the synthesis of derivatives 89 and 7 esters structurally related. Their preparations were achieved using classical procedures and the purified amides were submitted to spectroscopic and spectrometric characterization. The study of fragmentation process by EI and ESI suggested the preferential cleavage of the N-CO bond of cinnamamides, dienamides and cinnamimides. The cytotoxicity of 89 compounds was evaluated against three leukemic cells (K562, Nalm6 and Raji) and based on IC50 values the structure-activity relationship (SAR) was performed. While the K562 and Nalm6 cells were the more resistant and more sensitive, respectively, the amides piplartine (1a), N-cyclohexyl-N-(ciclohexylcarbamoyl)-3-(3,4,5-trimethoxyphenyl)propanamide (1n) and (E)-N,N-dibutyl-3-(3,4-dimethoxyphenyl)acrylamide (13h) were in general the most active with IC50 of 0.34 µM, 0.84 µM and 1.88 µM against K562 and (E)-N-cyclohexyl-N-(ciclohexylcarbamoyl)-3-(3,4-dimethoxyphenyl)acrylamide (13i) with IC50 of 0.98 µM against Nalm6. The evaluation of leishmanicidal activity of 18 substances was also performed but was not promising. Qualitative and quantitative approaches were made based on molecular descriptors generated by VolSurf+ program. The chemometric methods such as PLS, genetic algorithm, decision trees generated models to correlate molecular properties with the biological activity. The absorption, distribution, metabolism and excretion properties and a balance between hydrophilic and hydrophobic moieties of the amides were important for an optimized activity. The molecular docking revealed that amides such as (E)-N,N-dibutyl-3-(3,4,5-trimethoxyphenyl)acrylamide (1l), 1n, (E)-3-(4-chlorophenyl)-N-cyclohexil-N-(cyclohexylcarbamoyl)acrylamide (5a), 13h and 13i have potential to act as possible inhibitors of histone deacetylase proteins particularly HDAC4 and HDAC8.

Aujourd’hui, l’impact des conservateurs sur l’homme est remis en question. Il a été entrepris de mieux comprendre les agents antimicrobiens d’un point de vue physico-chimique pour fournir des règles de formulation, qui pourront être utilisées pour proposer à nos laboratoires de formulation des alternatives aux antimicrobiens classiquement utilisés. Ce travail a consisté en la compréhension des caractéristiques structurelles de molécules ayant, entre autre, des propriétés antimicrobiennes ; l’analyse des mécanismes physico-chimiques qui relient ces caractéristiques structurelles à leurs propriétés ; l’optimisation, à la lumière de ces informations, de la formulation de ces molécules. L’étude des familles chimiques, complétée par une étude plus large reliant la modélisation QSAR aux propriétés antimicrobiennes, a permis de conclure que certaines familles d’alcools et dérivés sont des alternatives de choix aux antimicrobiens usuels. Les caractéristiques permettant les meilleures performances étant : une structure asymétrique marquée ; une tête polaire comportant deux groupements hydrophiles, type diol ou mono glycéride ; une longueur de chaîne apolaire comprenant entre 6 et 12 carbones, avec un optimum entre 7 et 10 carbones ; le calcul du HLB résultant de ces caractéristiques donne un HLB compris entre 7 et 11. Les dérivés acides ou la famille des décanols ont permis de préciser l’intérêt d’une insaturation ou la présence d’un β-hydroxy. L’impact de la formulation d’une molécule modèle, le caprate/caprylate de glycérol a montré que dans une émulsion directe, les tensioactifs hydrophiles piègent dans leurs micelles l’actif, ce qui induit une diminution de l’activité antimicrobienne. L’épaisseur hydrophile des têtes polaires empêchent le passage de l’actif en dehors de la micelle vers le micro-organisme. Il est donc recommandé d’utiliser la quantité de tensioactif utile pour tapisser sans excès la surface des gouttes d’huiles. L’épaisseur des têtes polaires hydrophile peut être réduite en sélectionnant les tensioactifs, par exemple des ioniques phosphatés. D’autres paramètres ont été démontrés comme influant, dans une moindre mesure : il est recommandé de privilégier les gélifiants aux tensioactifs lors de l’élaboration d’une texture, d’optimiser le taux d’actif antimicrobien sur taux d’huile et d’utiliser de préférence des huiles peu solvantes de l’actif. / Nowadays, preservatives in personal care are obviously a current issue. The aim of this study was to find out rules for molecular design and formulation conception dealing with a physico-chemistry point of view, in order to avoid classic preservatives. We have studied on structural features for antimicrobial activity and their behaviors in direct emulsions. After studies of various structural families, and a wide QSAR analysis, the result was that molecule with one or two alcohol groups are among the better antimicrobial agents. Especially, we focus on some characteristics, which improve considerably the antimicrobial activity : an asymmetric structure ; a two-hydroxylated polar head like diols or monoglycerids ; the main hydrocarbon tail should contain between 6 and 12 carbons with an optimum between 7 and 10 ; with these characteristics, the HLB value must be located between 7 and 11. An unsaturated bond in a linear chain or a β-hydroxylated group leads to an increase of decontamination. The impact of the formulation in direct emulsions of a model molecule, glycerol octanoate/decanoate, seemed to show that hydrophilic surfactants trap in their micelles the active product, which induces a decrease of the antimicrobial activity. The hydrophilic thickness of polar heads prevents the passage of the active product beyond the micelle to the micro-organism. It is therefore recommended that the quantity of surfactant used to create and stabilize the drops of oil be reduce to a minimum. The hydrophilic thickness of polar heads may be reduced by selecting the surfactants, for example an ionic phosphate. Other parameters have been demonstrated as affecting, to a lesser extent: it is recommended polymers and micro gels are used rather than surfactants in the preparation of a texture to customize the ration antimicrobial on oil and to use preferably non-polar oil.

Environ un tiers des cancers est dû à la dérégulation du facteur de transcription c-Myc. Les mécanismes par lesquels ce facteur de transcription est impliqué dans le processus de cancérogenèse commencent à être mieux compris grâce notamment à l'identification de ses gènes cibles. Parmi eux a été identifié, à la fin des années 2000, le gène dnph1 codant pour une protéine surexprimée dans de nombreux cancers. Cependant, à ce jour, le rôle et la fonction biologiques de cette nouvelle cible thérapeutique restent méconnus. Cette protéine a été caractérisée au laboratoire comme étant une 2'-désoxyribonucléoside 5'-monophosphate N-hydrolase, activité jamais décrite jusqu'alors. Si les 2'-désoxyribonucléosides 5'-monophosphates sont substrats de cette enzyme, il a été montré que les ribonucléotides puriques canoniques sont des inhibiteurs compétitifs. Au cours de ces travaux de thèse, nous avons entrepris différentes études de relation structure-activité autour d'analogues ribonucléosidiques 5'-monophosphates dans le but d'identifier des inhibiteurs plus affins. Une première famille d’analogues modifiés en position 6 de la purine par différents groupements de taille et fonction variables a été synthétisée et les premiers inhibiteurs micromolaires de DNPH1 ont ainsi pu être identifiés. La co-cristallisation de certains composés avec l'enzyme a guidé la conception d'inhibiteurs de deuxième génération, modifiés en positions 6 et 2. Un léger effet additif sur les constantes d’inhibition a alors été observé et des inhibiteurs sub-micromolaires ont été identifiés. Des tests in vitro sur des lignées cellulaires cancéreuses surexprimant DNPH1 ont montré une activité cytotoxique micromolaire de certains des composés synthétisés. D'autres modifications portant sur la partie ribose-phosphate et le squelette purique ont été abordées dans le but de renforcer l'affinité et la stabilité biologique des inhibiteurs. L'ensemble de ces travaux a permis d'une part de mieux caractériser cette nouvelle cible et d'autre part d'identifier les premiers inhibiteurs micromolaires cytotoxiques. Ces résultats ouvrent des perspectives pour la conception de molécules plus efficaces. / About one third of the cancers is due to the deregulation of the transcription factor c-Myc. The gene dnph1 was identified a decade ago as a target gene of the c-Myc oncoprotein and encodes for a protein which is frequently over-expressed in several cancers. However, its biological role remains still unknown. It was recently shown that DNPH1 is a novel 2'-deoxyribonucleoside 5'-monophosphate N-hydrolase and that natural purine ribonucleotides act as competitive inhibitors. The aim of this thesis was the synthesis of strong inhibitors in order to study this new potential cancer target DNPH1. Several structure-activity relationships were built around ribonucleoside 5'-monophosphate derivatives. A first series of compounds modified at the 6 position of the purine core has been synthesized and enabled us to identify the first micromolar inhibitiors. Thanks to these inhibitors, X-ray structures of DNPH1 in interaction with inhibitors have been resolved and led us to the development of a new generation of analogues modified at the 6 and 2 positions. A slight additional effect on the inhibitory potency was noticed and some sub-micromolar inhibitors were identified. Among the synthesized compounds, several have shown micromolar cytotoxic effects against human cancer cells over-expressing DNPH1. Other modifications on the ribose-phosphate and the purine moieties have also been considered in order to increase both biological stability and affinity of the inhibitors. This work allowed a better characterization of the enzyme active site as well as the identification of new cytotoxic compounds. These results pave the way for the design of more potent inhibitors.